A US-backed Covid-19 vaccine has shown to be almost 95 percent effective.
30 thousand people took part in Moderna’s trial, which saw participants given two doses of either the vaccine or a placebo four weeks apart.
It comes just a week after Pfizer and BioNTech published early data that shows their vaccine is 90 per cent effective.